Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma

Table 2 Baseline characteristics of patients after treatment

Characteristics	3 d after treatment
Laboratory values, median (range)
WBC count, 109/L	4.985 (2.300-9.050)
Platelet count, 109/L	141 (44-259)
Hemoglobin, g/dL	136.5 (98.0-165.0)
Serum AST, IU/L	28.2 (15.0-103.7)
Serum ALT, IU/L	32.15 (8.40-74.30)
Serum total bilirubin, mg/dL	14.45 (5.40-44.80)
Serum albumin, g/dL	37.75 (24.30-46.30)
INR	1.08 (0.95-1.41)
Serum creatinine, mg/dL	65.7 (45.4-134.6)
Serum AFP, ng/mL, baseline < 20	5.60 (1.12-24200.00) (n = 29)
Serum AFP, ng/mL, baseline > 20	916.2 (21.1-24200.0) (n = 17)

WBC: White blood cell; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; INR: International Normalized Ratio; AFP: α-fetoprotein.